These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12091347)

  • 1. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
    Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
    Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
    Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
    Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
    Gillespie G; Mutis T; Schrama E; Kamp J; Esendam B; Falkenburg JF; Goulmy E; Moss P
    Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
    Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
    Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Oosten LE; Blokland E; van Halteren AG; Curtsinger J; Mescher MF; Falkenburg JH; Mutis T; Goulmy E
    Blood; 2004 Jul; 104(1):224-6. PubMed ID: 15031203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping.
    Verdijk RM; Mutis T; Wilke M; Pool J; Schrama E; Brand A; Goulmy E
    Hematol J; 2002; 3(6):271-5. PubMed ID: 12522448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity.
    Amrolia PJ; Reid SD; Gao L; Schultheis B; Dotti G; Brenner MK; Melo JV; Goldman JM; Stauss HJ
    Blood; 2003 Feb; 101(3):1007-14. PubMed ID: 12393606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses.
    den Haan JM; Mutis T; Blokland E; IJzerman AP; Goulmy E
    Blood; 2002 Feb; 99(3):985-92. PubMed ID: 11807003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.
    Oosten LE; Blokland E; Kester MG; Falkenburg JH; van Halteren AG; Goulmy E
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):151-63. PubMed ID: 17241921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
    Kloosterboer FM; van Luxemburg-Heijs SA; van Soest RA; Barbui AM; van Egmond HM; Strijbosch MP; Kester MG; Marijt WA; Goulmy E; Willemze R; Falkenburg JH
    Leukemia; 2004 Apr; 18(4):798-808. PubMed ID: 14973499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.
    Mommaas B; van Halteren AG; Pool J; van der Veken L; Wieles B; Heemskerk MH; Goulmy E
    Haematologica; 2005 Oct; 90(10):1415-21. PubMed ID: 16219579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
    Schilbach K; Kerst G; Walter S; Eyrich M; Wernet D; Handgretinger R; Xie W; Rammensee HG; Müller I; Bühring HJ; Niethammer D
    Blood; 2005 Jul; 106(1):144-9. PubMed ID: 15731181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.
    van der Torren CR; van Hensbergen Y; Luther S; Aghai Z; Rychnavská ZS; Slot M; Scherjon S; Kröger N; Ganser A; Weissinger EM; Goulmy E; Hambach L
    PLoS One; 2015; 10(3):e0119595. PubMed ID: 25774796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.
    Mommaas B; Stegehuis-Kamp JA; van Halteren AG; Kester M; Enczmann J; Wernet P; Kögler G; Mutis T; Brand A; Goulmy E
    Blood; 2005 Feb; 105(4):1823-7. PubMed ID: 15498856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.
    Heemskerk MH; Hoogeboom M; de Paus RA; Kester MG; van der Hoorn MA; Goulmy E; Willemze R; Falkenburg JH
    Blood; 2003 Nov; 102(10):3530-40. PubMed ID: 12869497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells.
    Kim YH; Vyth-Dreese FA; Schrama E; Pavel S; Bajema I; Goulmy E; Spierings E
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):69-77. PubMed ID: 20708701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
    Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
    Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.
    Marijt WA; Veenhof WF; Goulmy E; Willemze R; van Rood JJ; Falkenburg JH
    Blood; 1993 Dec; 82(12):3778-85. PubMed ID: 8260714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HA-1 mismatch has significant effect in chronic allograft nephropathy in clinical renal transplantation.
    Krishnan NS; Higgins RM; Lam FT; Kashi H; Jobson S; Ramaiyan K; Rahman M; Morris A
    Transplant Proc; 2007 Jun; 39(5):1439-45. PubMed ID: 17580157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.